TX-SONAR
Sonar, the leading Clean Code solution provider, has expanded its SonarCloud offering with the availability of two new plans, SonarCloud Enterprise and SonarCloud Team. SonarCloud, the company’s fully managed SaaS solution for improving the quality and security of human-developed and AI-assisted code at scale, is used by thousands of organizations to analyze proprietary and open source projects. With the new Enterprise and Team plans for SonarCloud, Sonar empowers development teams of all sizes to deliver Clean Code with confidence.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731528446/en/
Sonar Introduces SonarCloud Enterprise and Team Plans for Advanced Analysis of AI-assisted and Developer Written Code. (Graphic: Business Wire)
When code isn’t clean, it can cause business outages, security risks, and poor application performance. Sonar’s Clean Code solutions help developers catch bugs, quality concerns, and security flaws early in the development process, as code is being created. This allows them to find and resolve issues before they can make it through to production, improving developer productivity, software quality, and business performance.
“Our ROI in SonarCloud kicked in from the first month. We were able to gain a better understanding of the quality of our code and start rolling out suitable adjustments for the engineering team,” said Furkan Yavuz, QA lead for Recognyte, an AI-driven real estate intelligence company.
As organizations increasingly adopt AI assistants to write code and develop software, having scalable, flexible solutions, with high availability and built-in security has become a business imperative. The new SonarCloud plans ensure developer teams can leverage SonarCloud as their needs grow, to continuously reduce exposure to risk at all levels and sustain the performance of their software, growing business through systematic development and delivery.
“The adoption of AI coding assistants and the push for faster software development have increased code volume and raised reliability concerns. However, most code scanning tools are just adding to the growing list of issues that are potential threats to business, most of which are false positives. Developers need to be empowered to find issues early and be motivated to fix them with the tools they love and have confidence in. Development teams who use SonarCloud are able to pinpoint and remediate as early in the development process as possible,” said Fabrice Bellingard, VP of Product at Sonar.
Features Made for the Enterprise
SonarCloud Enterprise offers organization-wide portfolio management, new authentication and security features, executive reporting functionality, simplified administration, enterprise service-level agreements, and dedicated commercial support for all customers. Additionally, SonarCloud Enterprise is available on AWS Marketplace, ensuring simplified procurement and onboarding.
Centralizing Controls.
Managing multiple organizations in a DevOps environment can be difficult, causing a lack of visibility into the overall security of the company’s software and the needed actions to improve it on various levels. Specific features include: Enterprise hierarchy, portfolio creation, organization-wide configurable settings, project PDF reporting for technology leads and managers, and security standard reports for IT security teams.
Authentication and Security.
Organizations tend to use a combination of different tools in their DevOps toolkit to ensure code quality and security, on top of multiple linters to support the complexity that comes with leveraging a variety of languages. Managing organization and group membership to various solutions and ensuring they are synchronized can be a large administrative effort, and lead to security risks. Features that support this and ongoing security assurance include: Single Sign-On (SSO), synchronized access management, and more scalable token management.
Simplified Administration.
At onboarding, default settings can be prepared and applied to all projects with organization-wide project configuration. This relieves the tedious and slow task that large enterprises face of configuring a high number of projects, project by project. Automated project creation at scale also supports ease in standing up SonarCloud. It enables the auto-creation of projects in SonarCloud that were initially built in an enterprise DevOps platform. Additionally, enterprise billing means that billing can be done as a single entity while being applied to multiple organizations.
More about the SonarCloud Team Plan
Flexible plans to meet the needs of all organizations.
SonarCloud’s existing Private Repo plan has been replaced by SonarCloud Team and will continue to provide the reliable, SaaS solution that users trust and rely on today. At an affordable price, SonarCloud Team provides all the benefits of the SonarQube Community Edition plus additional features like branch analysis, pull request decoration, and injection flow detection. With the Team plan, developers can scan both public and private projects for actionable insights that enable consistent and efficient Clean Code delivery all in a simple, fast time-to-value SaaS model hosted by Sonar. Teams also have control to define the quality standard they want their codebase to follow.
As a company rooted in open source, the Free plan of SonarCloud will continue to be available and will evolve through the year.
SonarCloud on AWS Marketplace
SonarCloud is available on AWS Marketplace, a curated digital catalog of independent software vendors that make it easy to find, test, buy, and deploy software that runs on Amazon Web Services (AWS). This enables seamless access to Sonar’s SaaS solution and acceleration of its deployment for AWS customers globally, whether on the Enterprise or Team plan. Hosted at AWS and replicated across multiple availability zones, data remains accessible in case of hardware failures or natural disasters. In addition, Sonar has joined the AWS Independent Software Vendor (ISV) Accelerate Program, which will help it to provide improved customer support and cloud cost management. Through its membership in the program, Sonar will increase the visibility of its services to AWS customers and partners. More information about SonarCloud on AWS Marketplace can be found here.
“When developers aren’t burdened by fixing issues downstream, they have more time for creativity, quicker release cycles, and advanced problem-solving, which all support a more positive developer experience and contribute to higher retention and lower recruitment costs,” added Bellingard.
Features described in this release will be made available throughout 2024. To learn more, visit our SonarCloud page, here.
About Sonar
Sonar's Clean Code solutions, SonarQube, SonarCloud, and SonarLint, help developers prevent code quality and security issues from ever reaching production. Sonar analyzes all code, regardless of who writes it—your internal team or genAI—resulting in more secure, reliable, and maintainable software. Rooted in the open source community, Sonar’s solutions support over 30 programming languages, frameworks, and infrastructure technologies. Today, Sonar is used by 7M+ developers and 400K organizations worldwide, including the DoD, Microsoft, NASA, MasterCard, Siemens, and T-Mobile.
To learn more about Sonar, please visit: https://www.sonarsource.com/products/all/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240731528446/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom